Arterra Bioscience S.p.A. (BIT:ARBS)

Arterra Bioscience Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.31	1.34	3.34	3.69	4.39	4.81
Trading Asset Securities	-	-	-	-	1.6	-
Cash & Short-Term Investments	1.31	1.34	3.34	3.69	5.99	4.81
Cash Growth	-61.96%	-59.84%	-9.29%	-38.48%	24.46%	6.13%
Accounts Receivable	2.26	1.86	1.63	1.06	0.77	1.47
Other Receivables	1.92	2.11	1.98	1.78	1.88	1.71
Receivables	4.17	3.97	3.61	2.84	2.65	3.19
Inventory	1.35	1.54	1.33	1.36	1.16	0.49
Other Current Assets	0	0	0	0	0	0
Total Current Assets	6.83	6.88	8.29	7.89	9.81	8.49
Property, Plant & Equipment	1.81	1.68	1.51	1.23	1.54	1.66
Long-Term Investments	5.87	5.92	3.45	3.35	0.98	0.95
Other Intangible Assets	0.02	0.02	0.03	0.04	0.05	0.13
Long-Term Deferred Charges	0	0	0	-	0.15	0.31
Other Long-Term Assets	0.07	0.09	0.11	0.04	0.04	0.04
Total Assets	14.61	14.59	13.4	12.55	12.57	11.58

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.3	0.24	0.28	0.25	0.19	0.25
Accrued Expenses	0.57	0.46	0.31	0.43	0.32	0.69
Current Portion of Long-Term Debt	0.05	0.09	0.1	0.09	0.17	0.22
Current Income Taxes Payable	0.02	-	-	-	0.23	0.02
Other Current Liabilities	0.1	0.09	0.14	0.08	0.24	0.05
Total Current Liabilities	1.05	0.88	0.82	0.84	1.16	1.23
Long-Term Debt	0.19	0.17	0.26	0.3	0.32	0.39
Long-Term Deferred Tax Liabilities	0.41	0.39	0.38	0.22	0.24	0.2
Other Long-Term Liabilities	0.61	0.57	0.52	0.44	0.39	0.29
Total Liabilities	2.26	2.01	1.98	1.8	2.1	2.11

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.33	0.33	0.33	0.33	0.33	0.33
Additional Paid-In Capital	4.17	4.17	4.17	4.17	4.17	4.17
Retained Earnings	8.17	8.41	7.25	6.58	6.17	5.08
Treasury Stock	-0.33	-0.33	-0.33	-0.33	-0.2	-0.11
Shareholders' Equity	12.35	12.58	11.42	10.75	10.47	9.47
Total Liabilities & Equity	14.61	14.59	13.4	12.55	12.57	11.58

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.24	0.26	0.36	0.39	0.49	0.61
Net Cash (Debt)	1.07	1.08	2.99	3.3	5.5	4.2
Net Cash Growth	-65.82%	-63.77%	-9.48%	-40.03%	31.02%	12.69%
Net Cash Per Share	0.16	0.16	0.45	0.50	-	-
Filing Date Shares Outstanding	6.66	6.66	6.66	6.66	-	-
Total Common Shares Outstanding	6.66	6.66	6.66	6.66	-	-
Working Capital	5.78	6	7.47	7.04	8.65	7.26
Book Value Per Share	1.85	1.89	1.72	1.61	-	-
Tangible Book Value	12.33	12.56	11.39	10.71	10.42	9.34
Tangible Book Value Per Share	1.85	1.89	1.71	1.61	-	-
Land	1.22	1.15	1.09	0.72	0.72	0.61
Machinery	2.99	2.92	2.57	2.43	2.41	2.61
Construction In Progress	0.02	0.02	0.01	-	-	0.01

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 15, 2026

Data Sources Report a data error